Martín, M., Chacón, J., Antón, A., Plazaola, A., García-Martínez, E., Seguí, M., . . . Antolin, S. (2017). Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis.
Citación estilo ChicagoMartín, M., et al. Neoadjuvant Therapy With Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results From the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, With a Companion Biomarker Analysis. 2017.
Cita MLAMartín, M., et al. Neoadjuvant Therapy With Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results From the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, With a Companion Biomarker Analysis. 2017.